7000 Cardinal Place
431 articles with Cardinal Health
The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.
CoolSource™ Cooling System lowers heat induced stress for surgical staff
A New Survey from Cardinal Health Reveals Demands on Hospital Leaders' Time Take a Toll on Ability to Drive Innovation
Three ways the hospital pharmacy can improve hospital profitability and patient outcomes
GAAP(1) operating earnings increased 26 percent to $504 million, and non-GAAP operating earnings decreased 13 percent to $637 million
Cardinal Health Announces Brian Rice as EVP, Chief Information Officer and Customer Support Services
Cardinal Health (NYSE: CAH) today announced that Brian Rice will join the company as executive vice president, chief information officer and customer support services. Rice's most recent role was senior vice president, chief information officer and global business services for Kellogg Company.
Cardinal Health Foundation Supports New Initiatives at the Ohio Hospital Association to Spread Best Practices in Opioid Prescribing
Partnership builds on Cardinal Health's Opioid Action Program and Generation Rx
Cardinal Health today announced that its board of directors has elected J. Michael Losh as an independent director effective December 5. Losh will serve as the chairman of the Audit Committee.
Assessments by AmerisourceBergen, Cardinal Health, and McKesson Pharmaceutical Shows Nearly 80 Percent of Suppliers' Packages Do Not Meet Requirements
Cardinal Health (NYSE: CAH) today announced that Victor Crawford will be joining the company as its next CEO of the Pharmaceutical Segment.
Cardinal Health plans to release first-quarter financial results for its fiscal year 2019 on November 8 prior to the opening of trading on the New York Stock Exchange.
Telix Pharmaceuticals and Cardinal Health Enter into Distribution Agreement for Prostate Cancer Imaging
Telix Pharmaceuticals (US) Inc. today announced that it has entered into a distribution agreement with Cardinal Health (NYSE:CAH).
Emmaus, a Leader in Sickle Cell Disease Treatment, Signs Agreement with Cardinal Health to Solidify Distribution Network for Endari™ (L-glutamine oral powder)
Company Signs Fourth Major Distribution Agreement this Year
Purdue Pharma, best known for being the manufacturer of opioid drug OxyContin, is offering free doses of a treatment for opioid abuse as part of negotiations in more than 1,000 lawsuits.
The Cardinal Health (NYSE: CAH) board of directors approved a quarterly dividend of $0.4763 per share. The dividend will be payable on October 15, 2018 to shareholders of record at the close of business on October 1, 2018.
Fourth-quarter revenue increased 7 percent to $35 billion; full-year revenue increased 5 percent to $137 billion
Cardinal Health and Clayton, Dubilier & Rice Announce Partnership to Accelerate Growth of naviHealth
Investment Accelerates naviHealth's Growing Market Position in Post-Acute Care Management
FDA Advisory Committee Votes in Favor of Cardinal Health's INCRAFT® AAA Stent Graft System for the Endovascular Treatment of Infrarenal Abdominal Aortic Aneurysms
Cardinal Health announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee has provided a favorable recommendation on the premarket approval application for INCRAFT® AAA Stent Graft System (INCRAFT).
The medical device market was about $521.2 billion last year and is projected to hit $674.5 billion by 2022. Here’s a look at the top 10 medical device companies in the world this year.
While nearly four in 10 oncologists view precision medicine as a potential game-changer, most (57 percent) say it's too soon to predict its long-term impact, according to new research from Cardinal Health Specialty Solutions.
Sitting before a Congressional panel Tuesday the heads of pharmaceutical distributing companies said their mea culpas over not doing more to limit the flow of prescription opioids to certain parts of the country.